FRM
ASND icon

Fox Run Management’s Ascendis Pharma A/S ASND Stock Holding History

Fox Run Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,496
Closed -$959K – 903
2025
Q4 		$959K Buy
4,496
+2,830
+170% +$584K 0.15% 227
2025
Q3 		$331K Buy
+1,666
New +$311K 0.05% 653
2024
Q3 		– Sell
-3,613
Closed -$493K – 792
2024
Q2 		$493K Buy
+3,613
New +$492K 0.09% 415
2024
Q1 		– Sell
-2,986
Closed -$376K – 746
2023
Q4 		$376K Buy
+2,986
New +$298K 0.1% 417
2023
Q2 		– Sell
-4,427
Closed -$475K – 679
2023
Q1 		$475K Buy
+4,427
New +$506K 0.15% 234

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return